Versigent reports $102 million net income for Q3 2026

Cover page 2 changes

3 unchanged paragraphs

For the quarterly period ended June September 30, 2026

20 unchanged paragraphs

The number of the registrant's ordinary shares outstanding, $0.01 par value per share as of July 31, October 30, 2026, was 70,835,265 70,844,658 .

1 unchanged paragraph

Financial statements 165 changes

1 unchanged paragraph

Three Months Ended June 30, Six Months Ended June 30,

Net sales $ 2,444 $ 2,206 $ 4,656 $ 4,230

Cost of sales 2,123 1,943 4,091 3,718

Selling, general and administrative 100 104 197 209

Restructuring (Note 9) — 25 46 41

Separation costs 22 2 48 7

Total operating expenses 2,245 2,075 4,383 3,976

Operating income 199 131 273 254

Interest expense ( 36 ) ( 1 ) ( 41 ) ( 3 )

Income before equity income 111 109 188 200

Net income 116 112 197 208

Net (loss) income attributable to noncontrolling interest ( 2 ) 5 1 6

Basic earnings per share:

Weighted average number of basic shares outstanding 70.90 70.89 70.90 70.89

Diluted earnings per share:

Diluted earnings per share attributable to Versigent

Weighted average number of diluted shares outstanding 71.88 70.89 71.39 70.89

Three Months Ended September 30, Nine Months Ended September 30, (in millions, except per share amounts)

Net sales $ 2,450 $ 2,286 $ 7,106 $ 6,516

Cost of sales 2,120 1,990 6,211 5,708

Selling, general and administrative 112 104 309 313

Amortization — 1 — 1 1

Restructuring (Note 9) 22 21 68 62

Separation costs 11 7 59 14

Total operating expenses 2,265 2,122 6,648 6,098

Operating income 185 164 458 418

Interest expense ( 36 ) — ( 77 ) ( 3 )

Other expense, net (Note 18) ( 6 2 ) — ( 7 9 ) ( 1 )

Income before income taxes and equity income 157 130 225 250 147 164 372 414

Income tax expense (Note 13) ( 46 35 ) ( 21 54 ) ( 37 72 ) ( 50 104 )

Income before equity income 112 110 300 310

Equity income, net of tax 5 — 3 9 8 11

Net income 112 113 309 321

Net income attributable to noncontrolling interest 10 4 11 10

Net income attributable to Versigent $ 118 102 $ 107 109 $ 196 298 $ 202 311

Basic Earnings per share attributable to Versigent:

Basic $ 1.44 $ 1.54 $ 4.20 $ 4.39

Diluted $ 1.41 $ 1.54 $ 4.16 $ 4.39

Weighted average shares outstanding:

Basic 70.85 70.89 70.88 70.89

Diluted 72.25 70.89 71.67 70.89

2 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Net income $ 116 $ 112 $ 197 $ 208

Other comprehensive income:

Currency translation adjustments ( 3 ) 41 ( 30 ) 57

Other comprehensive income 18 41 75 57

Comprehensive income 134 153 272 265

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Net income $ 112 $ 113 $ 309 $ 321

Other comprehensive (loss) income:

Currency translation adjustments 4 ( 6 ) ( 26 ) 51

Net change in unrecognized (loss) gain on derivative instruments, net of tax (Note 15) 19 ( 106 30 ) — 76 —

Employee benefit plans adjustment, net of tax (Note 15) 2 — ( 1 ) 1 — 1

Other comprehensive (loss) income ( 25 ) ( 5 ) 50 52

Comprehensive income 87 108 359 373

Comprehensive income attributable to noncontrolling interests 8 6 12 7 10 4 22 11

Comprehensive income attributable to Versigent $ 126 77 $ 147 104 $ 260 337 $ 258 362

2 unchanged paragraphs

Cash and cash equivalents $ 554 638 $ 276

3 unchanged paragraphs

Property, net 901 901

Total current assets 3,540 3,667 2,773

Property, net 913 901

Operating lease right-of-use assets 192 213 168

2 unchanged paragraphs

Deferred tax assets 443 450 384

1 unchanged paragraph

Total long-term assets 1,819 1,860 1,712

Total assets $ 5,359 5,527 $ 4,485

3 unchanged paragraphs

Accounts payable 1,666 1,772 1,530

1 unchanged paragraph

Total current liabilities 2,532 2,567 2,166

2 unchanged paragraphs

Pension benefit obligations 214 216 217

Long-term operating lease liabilities 144 164 130

1 unchanged paragraph

Total long-term liabilities 2,543 2,597 471

Total liabilities 5,075 5,164 2,637

3 unchanged paragraphs

Ordinary shares, $ 0.01 par value per share, 1,200,000,000 shares authorized, 70,925,978 70,841,248 issued and 70,815,717 outstanding as of June September 30, 2026

Additional paid-in-capital 143 144 —

Retained earnings 118 211 —

2 unchanged paragraphs

Noncontrolling interest 199 191

Total Versigent shareholders' equity 85 154 1,657

Noncontrolling interest 209 191

Total shareholders' equity 284 363 1,848

Total liabilities and shareholders' equity $ 5,359 5,527 $ 4,485

2 unchanged paragraphs

Six Months Ended June 30,

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

3 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

3 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

4 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

and 85 more changes in the filing

Note 1: BUSINESS AND BASIS OF PRESENTATION 1 change

3 unchanged paragraphs

We also develop, manufacture and sell our solutions to a number of adjacent end markets. including agriculture, construction, These markets include our commercial vehicles business, as well as agriculture, construction, and grid and infrastructure, and have begun exploring other industrial end markets, including off-grid power storage and robotics. With a proven portfolio of solutions, we expect to leverage our long-standing customer relationships, technical expertise within power, data and signal distribution, and capabilities built serving the global automotive industry to further penetrate these adjacent markets.

8 unchanged paragraphs

Note 2: SIGNIFICANT ACCOUNTING POLICIES 9 changes

9 unchanged paragraphs

Versigent primarily utilizes historical loss and recovery data, consolidated with information on current economic conditions and reasonable and supportable forecasts to develop the estimate of the allowance for doubtful accounts in accordance with ASC Topic 326, Financial Instruments – Credit Losses ("ASC 326"). As of June September 30, 2026 and December 31, 2025, the Company reported $ 1,877 1,944 million and $ 1,567 million, respectively, of accounts receivable, net of the allowances, which includes the allowance for doubtful accounts of $ 18 million and $ 17 million, respectively. The Company recorded Bad debt expense which was de minimis $ 1 million for both the three and six nine months ended June September 30, 2026. Bad debt expense was de minimis $ 4 million and $ 6 10 million for the three and six nine months ended June September 30, 2025, respectively, The expense recorded during the six-month period was primarily related to a certain local customer that ceased operations customers in China. Other changes in the allowance were no t material for the three and six nine months ended June September 30, 2026 and June September 30, 2025. Generally, the Company does not require collateral for its accounts receivable.

Inventories —As of June September 30, 2026 and December 31, 2025, inventories are stated at the lower of cost, determined on a first-in, first-out basis, or net realizable value, including direct material costs and direct and indirect manufacturing costs. Refer to Note 4. Inventories for additional information.

1 unchanged paragraph

Intangible assets —Intangible assets were $ 6 5 million and $ 7 million as of June September 30, 2026 and December 31, 2025, respectively. The Company amortizes definite-lived intangible assets over their estimated useful lives. The Company has definite-lived intangible assets related to patents and developed technology, customer relationships and trade names. Costs to renew or extend the term of acquired intangible assets are recognized as expense as incurred. Amortization expense was de minimis and $ 1 million for both the three months ended June September 30, 2026 and 2025. respectively. Amortization expense was $ 1 $1 million for both the six nine months ended June September 30, 2026 and 2025.

3 unchanged paragraphs

Foreign currency translation —Assets and liabilities of non-U.S. subsidiaries that use a currency other than U.S. dollars as their functional currency are translated to U.S. dollars at end-of-period currency exchange rates. The consolidated statements of operations of non-U.S. subsidiaries are translated to U.S. dollars at average-period currency exchange rates. The effect of translation for non-U.S. subsidiaries is generally reported in other comprehensive income (loss) ("OCI"). The accumulated foreign currency translation adjustment related to an investment in a foreign subsidiary is reclassified to net income (loss) upon sale or upon complete or substantially complete liquidation of the respective entity. The effect of remeasurement of assets and liabilities of non-U.S. subsidiaries that use the U.S. dollar as their functional currency is primarily included in cost of sales. Also included in cost of sales are gains and losses arising from transactions denominated in a currency other than the functional currency of a particular entity. Net foreign currency transaction losses gains of $ 2 3 million and losses of $ 10 6 million were included in the consolidated statements of operations for the three months ended June September 30, 2026 and 2025, respectively. Net foreign currency transaction gains of $ 2 5 million and losses of $ 12 18 million were included in the consolidated statements of operations for the six nine months ended June September 30, 2026, and 2025, respectively.

1 unchanged paragraph

Customer concentrations —We sell our products and services to the major global OEMs in every region of the world. Our ten largest customers accounted for approximately 83 % and 81 % of our total net sales for both the three and six nine months ended June September 30, 2026. respectively. For the three months ended June September 30, 2026, three customers each accounted for more than 10% of our consolidated net sales at 20 19 %, 18 19 % and 14 15 %, respectively. For the six nine months ended June September 30, 2026, the three customers accounted for 18 %, 18 % and 14 % of consolidated net sales, respectively.

For the three and six nine months ended June September 30, 2025, our ten largest customers accounted for approximately 79 % and 80 % of our total net sales respectively. for each period. For the three and six months ended June September 30, 2025, three customers each accounted for more than 10% of our consolidated net sales at 20 %, 15 % and 12 %, respectively. For the nine months ended September 30, 2025, three customers each accounted for more than 10% of consolidated net sales at 19 %, 14 %, and 12 % of consolidated net sales, respectively.

3 unchanged paragraphs

Foreign exchange forward contracts are accounted for as hedges of firm or forecasted foreign currency commitments or foreign currency exposure of the net investment in certain foreign operations to the extent they are designated and assessed as highly effective. All foreign exchange contracts are marked to market on a current basis. Commodity swaps are accounted for as hedges of firm or anticipated commodity purchase contracts to the extent they are designated and assessed as effective. All other commodity derivative contracts that are not designated as hedges are either marked to market on a current basis or are exempted from mark to market accounting as normal purchases. At June September 30, 2026 and December 31, 2025, the Company's exposure to movements in interest rates was not hedged with derivative instruments.

2 unchanged paragraphs

In addition, beginning in the fourth quarter of 2025, liabilities related to inactive employees in Germany under a Former Parent-sponsored plan that had not yet legally transferred to the Company due to regulatory reasons were attributed to the Company. These liabilities were legally transferred in the third quarter of 2026. Prior to completion of the legal transfer, the Former Parent will pay paid the benefits due to these inactive employees on behalf of Versigent and Versigent will reimburse reimbursed the Former Parent. These liabilities are expected to be legally transferred by the end of 2026.

5 unchanged paragraphs

In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. The amendments in this update exclude from derivative accounting non exchange-traded contracts with underlyings that are based on operations or activities specific to one of the parties to the contract. The amendments also provide clarification for share-based payments from a customer in a revenue contract. The new guidance will be applied prospectively and is effective for fiscal years beginning after December 15, 2026, and interim periods within those annual reporting periods, with the option to apply retrospectively. Early adoption is permitted. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements.

3 unchanged paragraphs

Note 3: RELATED-PARTY TRANSACTIONS 20 changes

5 unchanged paragraphs

Prior to the Spin-Off, net sales of products from Versigent to affiliates of the Former Parent totaled $ 2 million for the three months ended March 31, 2026. Net sales of products from Versigent to affiliates of the Former Parent were de minimis and $ 1 million and $ 2 million for the three and six nine months ended June September 30, 2025, respectively.

Prior to the Spin-Off, total purchases from affiliates of the Former Parent totaled $ 192 million for the three months ended March 31, 2026. Total purchases from affiliates of the Former Parent totaled $ 201 206 million and $ 387 593 million for the three and six nine months ended June September 30, 2025, respectively.

4 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Cost of sales $ — $ 37 $ 13 $ 56

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Cost of sales $ — $ 38 $ 13 $ 94

Selling, general and administrative — 78 81 80 156 237

Restructuring — 1 — — 1

Total allocated costs from Former Parent $ — $ 116 119 93 213 332

3 unchanged paragraphs

Six Months Ended June 30,

Nine Months Ended September 30,

Cash pooling and general financing activities, net $ ( 133 106 ) $ ( 47 457 )

Corporate cost allocations 93 213 332

Income taxes (1) ( 7 ) ( 32 ) 6

Net transfers to from Former Parent per consolidated statements of cash flows ( 47 20 ) 134 ( 119 )

Transfer of net assets with Former Parent ( 17 16 ) —

Related party receivables exchanged with Former Parent 28 — 53

1 unchanged paragraph

Net transfers from (to) Former Parent per consolidated statements of shareholders' equity (2) $ 17 $ ( 66 )

Net transfers from Former Parent per consolidated statements of shareholders' equity (2) $ 17 $ 134 (1) Represents non-cash income tax impacts incurred in the respective period as a result of the application of the separate return basis with respect to the income tax provision and related balance sheet accounts within the consolidated financial statements, as further described in Note 13. Income Taxes, as well as taxes paid by the Former Parent.

(2) Net transfers to from Former Parent per consolidated statements of shareholders' equity was $ 36 ) million and $ 95 200 million for the three months ended June September 30, 2026 and 2025. respectively.

Note 4: INVENTORIES 5 changes

1 unchanged paragraph

Productive material $ 392 $ 382

Finished goods 270 292

Productive material $ 419 $ 382

Work-in-process 110 118 98

Finished goods 284 292

Note 5: ASSETS 11 changes

1 unchanged paragraph

Notes receivable 51 —

Value added tax receivable $ 104 101 $ 65

Derivative financial instruments (Note 16) 96 71 —

Prepaid insurance and other expenses 31 47 31

Income and other taxes receivable 34 25 40

Reimbursable engineering costs 12 8 12

2 unchanged paragraphs

Capitalized upfront fees (Note 20) $ 25 26 $ 26

Long-term receivables 26 15

Reimbursable engineering costs 19 23 20

Derivative financial instruments (Note 16) 20 10 —

Debt issuance costs 9 8 —

2 unchanged paragraphs

Note 6: INVESTMENTS IN AFFILIATES 1 change

1 unchanged paragraph

As part of Versigent's operations, it has investments in two non-consolidated affiliates accounted for under the equity method of accounting. These affiliates are not publicly traded companies and are located in North America and Asia Pacific. The most significant investment is in Promotora de Partes Electricas Automotrices, S.A. de C.V. (of which Versigent owns approximately 40 %). The Company's aggregate investments in affiliates was $ 149 146 million and $ 143 million as of June September 30, 2026 and December 31, 2025, respectively. No dividends were received from non-consolidated affiliates for the three months ended June September 30, 2026. Dividends of $ 8 3 million for the three months ended June September 30, 2025 were received from non-consolidated affiliates. Dividends of $ 2 million and $ 8 11 million for the six nine months ended June September 30, 2026 and June 30, 2025, respectively, were received from these non-consolidated affiliates. There were no impairment charges recorded for the three and six nine months ended June September 30, 2026 and 2025.

1 unchanged paragraph

Note 7: LIABILITIES 14 changes

1 unchanged paragraph

Accrued freight 43 35

Payroll-related obligations $ 214 223 $ 178

Income and other taxes payable 114 94 94

Operating lease liabilities 55 56 52

Accrued interest 36 55 —

Employee benefits, including current pension obligations 43 55 36

Restructuring (Note 9) 53 52 46

Accrued freight 40 35

Outside services 34 24

1 unchanged paragraph

Outside services 27 24

Warranty obligations (Note 8) 15 16 14

1 unchanged paragraph

Accrued income taxes 45 $ 57 $ 31

Deferred income taxes, net 50 53 29

Restructuring (Note 9) 3 11 3

1 unchanged paragraph

Note 8: WARRANTY OBLIGATIONS 4 changes

Expected warranty costs for products sold are recognized principally at the time of sale of the product based on an estimate of the amount that eventually will be required to settle such obligations. These accruals are based on factors such as past experience, production changes, industry developments and various other considerations. The estimated costs related to product recalls based on a formal campaign soliciting return of that product are accrued at the time an obligation becomes probable and can be reasonably estimated. These estimates are adjusted from time to time based on facts and circumstances that impact the status of existing claims. The Company has recognized a reasonable estimate for its total aggregate warranty reserves, including product recall costs, as of June September 30, 2026. At June September 30, 2026, the difference between the recorded liabilities and the reasonably possible range of potential loss was not material.

The table below summarizes the activity in the product warranty liability for the six nine months ended June September 30, 2026:

2 unchanged paragraphs

Provision for estimated warranties incurred during the period 8 12

1 unchanged paragraph

Accrual balance at June September 30, 2026 $ 15 16

Note 9: RESTRUCTURING 11 changes

1 unchanged paragraph

As part of the Company's continued efforts to optimize its cost structure, it has undertaken several restructuring programs which include workforce reductions as well as plant closures. These programs are primarily focused on reducing global overhead costs, the continued rotation of our manufacturing footprint to best cost locations in Europe and aligning our manufacturing capacity with the current levels of automotive production in each region. The Company recorded employee-related and other restructuring charges related to these programs which were de minimis of $ 22 million during the three months ended June September 30, 2026 and approximately $ 46 68 million during the six nine months ended June September 30, 2026. Charges for the six three and nine months ended June September 30, 2026 included the recognition of approximately $ 14 million due to an early service contract cancellation in North America. Charges for the nine months ended September 30, 2026 also included the recognition of approximately $ 33 million for a program to downsize and close a European manufacturing site.

There have been no changes in previously initiated programs that have resulted, or are expected to result, in a material change to our restructuring costs. The Company expects to incur additional restructuring costs pursuant to approved programs of approximately $ 15 43 million, for approved programs including $ 28 million related to a program focused on global workforce alignment, all of which are expected to be incurred within the next twelve months.

During the three and six nine months ended June September 30, 2025, restructuring charges approximated $ 25 21 million and $ 41 62 million, respectively, which included the recognition of approximately $ 9 12 million and $ 22 34 million, respectively, for charges incurred to downsize European sites.

Restructuring charges for employee separation and termination benefits are paid either over the severance period or in a lump sum in accordance with either statutory requirements or individual agreements. Versigent incurred cash expenditures related to its restructuring programs of approximately $ 37 48 million and $ 28 41 million in the six nine months ended June September 30, 2026 and 2025, respectively.

The table below summarizes the activity in the restructuring liability for the six nine months ended June September 30, 2026:

2 unchanged paragraphs

Accrual balance at June 30, 2026 $ 56 $ — $ 56

Provision for estimated expenses incurred during the period 57 — 57 65 15 80

Change in estimate ( 11 12 ) — ( 11 12 )

Payments made during the period ( 37 47 ) ( 1 ) 37 ( 48 )

Foreign currency and other ( 2 6 ) — ( 2 6 )

Accrual balance at September 30, 2026 $ 49 $ 14 $ 63

Note 10: DEBT 11 changes

The following is a summary of debt outstanding, net of unamortized issuance costs, as of June September 30, 2026 and December 31, 2025:

3 unchanged paragraphs

Finance leases and other 151 51 61

Less: current portion ( 153 58 ) ( 58 )

Long-term debt $ 2,071 2,066 $ 3

On November 26, 2025, Versigent PLC and its wholly-owned subsidiaries Cyprium Versigent Corporation ("Cyprium ("Versigent U.S.") and (formerly known as Cyprium Corporation) and Versigent Holdings Luxembourg S.À.R.L ("Versigent Luxembourg") (formerly known as Cyprium Holdings Luxembourg S.À.R.L), entered into a credit agreement (the "Credit Agreement") with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent (the "Administrative and domestic collateral agent, and Wilmington Trust, National Association, as foreign collateral agent, with respect to $ 1.35 billion in senior secured credit facilities. The agreement was subsequently amended on March 25, 2026 and, as amended, is referred to herein as the "Credit Agreement". The Credit Agreement consists of a senior secured five-year $ 500 million term loan facility (the "Term Loan A Facility") and a five-year $ 850 million senior secured revolving credit facility (the "Revolving Credit Facility", together with the Term Loan A Facility, the "Credit Facilities"). with the lenders party thereto and JPMorgan Chase Bank, N.A. The Credit Facilities became available to Versigent PLC in connection with the Spin-Off. Approximately $ 15 million in debt issuance costs were incurred in connection with the Credit Agreement.

As of June September 30, 2026, Versigent had no amounts outstanding under the Revolving Credit Facility and no letters of credit have been issued under the Credit Agreement. Letters of credit issued under the Credit Agreement reduce availability under the Revolving Credit Facility.

5 unchanged paragraphs

Cyprium Versigent U.S. and Cyprium Versigent Luxembourg are each borrowers under the Credit Agreement, under which such borrowings are guaranteed by Versigent PLC. Additional subsidiaries of Versigent PLC may be added as co-borrowers or guarantors under the Credit Agreement from time to time on the terms and conditions set forth in the Credit Agreement. The obligations of each borrower under the Credit Agreement will be jointly and severally guaranteed by each other borrower and by certain of our existing and future direct and indirect subsidiaries, subject to certain exceptions customary for financings of this type. All obligations of the borrowers and the guarantors will be secured by certain assets of such borrowers and guarantors, including a perfected first-priority pledge of all of the capital stock in Versigent PLC.

1 unchanged paragraph

June September 30, 2026 December 31, 2025

4 unchanged paragraphs

On March 18, 2026, Cyprium Versigent U.S. and Cyprium Versigent Luxembourg issued $ 800 million aggregate principal amount of their 6.125 % senior notes due 2031 (the "2031 Notes") and $ 800 million aggregate principal amount of their 6.375 % senior notes due 2034 (the "2034 Notes" and, together with the 2031 Notes, the "Notes"). The Notes were sold to investors in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended. Approximately $ 23 million in debt issuance costs were incurred in connection with the issuance of the Notes.

3 unchanged paragraphs

Finance leases and other —As of June September 30, 2026 and December 31, 2025, approximately $ 151 51 million and $ 61 million, respectively, of other debt primarily issued by certain non-U.S. subsidiaries and finance lease obligations were outstanding.

Interest —Cash paid for interest related to debt outstanding totaled $ 3 18 million and $ 2 million for the six nine months ended June September 30, 2026 and 2025, respectively.

Note 11: PENSION BENEFITS 14 changes

2 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Service cost $ 3 $ 2 $ 6 $ 3

Interest cost 5 2 11 4

Settlement loss 2 — 2 —

The amounts shown below reflect the defined benefit pension expense for the three and six nine months ended June September 30, 2026 and 2025:

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Service cost $ 3 $ 1 $ 9 $ 4

Interest cost 6 2 17 6

Expected return on plan assets ( 1 ) ( 1 ) 2 ( 3 ) ( 1 )

Settlement loss 1 — 3 —

1 unchanged paragraph

Amortization of actuarial losses — 1 — 1

Net periodic benefit cost $ 9 $ 4 3 $ 21 30 $ 7 10

Other postretirement benefit obligations as of June September 30, 2026 were de minimis was $ 1 million and there were no other postretirement benefit obligations as of December 31, 2025.

1 unchanged paragraph

As described in Note 2. Significant Accounting Policies, prior to the legal split of plans in 2025, certain of the Company's employees, primarily in Mexico and Germany, participated in the Shared Plans sponsored by the Former Parent. The Company recorded an expense of approximately $ 1 million and $ 2 3 million for the three and six nine months ended June September 30, 2025, respectively, to record its allocation of pension benefit service costs related to the Shared Plans.

Note 12: COMMITMENTS AND CONTINGENCIES 1 change

3 unchanged paragraphs

The Company is subject to the requirements of U.S. federal, state, local and non-U.S. environmental, health and safety laws and regulations. As of June September 30, 2026 and December 31, 2025, the undiscounted reserve for environmental investigation and remediation recorded in other liabilities were de minimis. The Company cannot ensure that environmental requirements will not change or become more stringent over time or that its eventual environmental remediation costs and liabilities will not exceed the amount of its current reserves. In the event that such liabilities were to significantly exceed the amounts recorded, the Company's results of operations could be materially affected. At June September 30, 2026, the difference between the recorded liabilities and the reasonably possible range of potential loss was not material.

Note 13: INCOME TAXES 11 changes

2 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

(dollars in millions)

Income tax expense $ 46 $ 21 $ 37 $ 50

Effective tax rate 29 % 16 % 16 % 20 %

The Company's income tax expense and effective tax rates for the three and six nine months ended June September 30, 2026 and 2025 were as follows:

Three Months Ended September 30, Nine Months Ended September 30, (dollars in millions)

Income tax expense $ 35 $ 54 $ 72 $ 104

Effective tax rate 24 % 33 % 19 % 25 %

1 unchanged paragraph

The Company's effective tax rate for the three months ended June September 30, 2026 and 2025 includes net discrete tax expenses of approximately $ 2 million and net discrete tax benefits expenses of $ 6 20 million, respectively. The net discrete tax expenses for the three months ended June September 30, 2026 are primarily related to changes in reserves. The net discrete tax benefits expenses for the three months ended June September 30, 2025 are primarily related to provision to return adjustments and changes in valuation allowances.

The Company's effective tax rate for the six nine months ended June September 30, 2026 and 2025 includes net discrete tax benefits of approximately $ 22 19 million and net discrete tax benefits expenses of $ 4 16 million, respectively. The net discrete tax benefits for the six nine months ended June September 30, 2026 are primarily related to changes in reserves. The net discrete tax benefits expenses for the six nine months ended June September 30, 2025 are primarily related to provision to return adjustments and changes in valuation allowances.

1 unchanged paragraph

Cash paid or withheld for income taxes was $ 50 74 million and $ 57 72 million for the six nine months ended June September 30, 2026 and 2025, respectively.

3 unchanged paragraphs

Note 14: SHAREHOLDERS' EQUITY AND EARNINGS PER SHARE 13 changes

3 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Three Months Ended September 30, Nine Months Ended September 30, (in millions, except per share data)

1 unchanged paragraph

Weighted average ordinary shares outstanding, basic 70.90 70.85 70.89 70.90 70.88 70.89

Dilutive shares related to restricted stock units 0.98 1.40 — 0.49 0.79 —

Weighted average ordinary shares outstanding, including dilutive shares 71.88 72.25 70.89 71.39 71.67 70.89

1 unchanged paragraph

Basic $ 1.66 $ 1.51 $ 2.76 $ 2.85

Diluted $ 1.64 $ 1.51 $ 2.75 $ 2.85

Basic $ 1.44 $ 1.54 $ 4.20 $ 4.39

Diluted $ 1.41 $ 1.54 $ 4.16 $ 4.39

2 unchanged paragraphs

The Company has declared and paid cash dividends per ordinary share during the periods presented as follows:

Dividend Per Ordinary Share Amount (in millions)

Third quarter $ 0.13 $ 9

In addition, on August November 3, 2026, our Board of Directors declared a quarterly cash dividend of $ 0.13 per ordinary share, payable on September 18, December 17, 2026 to shareholders of record at the close of business on September December 4, 2026. The announcement and payment of cash dividends on our ordinary shares in the future, in this amount or otherwise, will be within the discretion of our Board of Directors at such time.

Note 15: CHANGES IN ACCUMULATED OTHER COMPREHENSIVE LOSS 30 changes

Three Months Ended June 30, Six Months Ended June 30,

The changes in accumulated other comprehensive loss attributable to Versigent (net of tax) for the three and six nine months ended June September 30, 2026 and 2025 are shown below:

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

1 unchanged paragraph

Balance at beginning of period $ ( 291 277 ) $ ( 321 281 ) $ ( 263 ) $ ( 337 )

Aggregate adjustment for the period 4 ( 13 6 ) 40 ( 41 37 ) 56 50

Net transfers from Former Parent 27 — — 27 —

Balance at end of period ( 277 273 ) ( 281 287 ) ( 277 273 ) ( 281 287 )

1 unchanged paragraph

Balance at beginning of period 87 106 — — —

Other comprehensive income before reclassifications (net tax effect of $ 8 0 , $ 0 , ( $( 24 ) and $ 0 )

Reclassification to income (net tax effect of $ 5 6 , $ 0 , 5 $ 11 and $ 0 )

Balance at end of period 106 76 — 106 76 —

1 unchanged paragraph

Balance at beginning of period ( 8 6 ) ( 4 ) ( 5 ) ( 4 )

2 unchanged paragraphs

Balance at end of period ( 6 5 ) ( 4 3 ) ( 6 5 ) ( 4 3 )

Accumulated other comprehensive loss, end of period $ ( 177 202 ) $ ( 285 290 ) $ ( 177 202 ) $ ( 285 290 )

Reclassifications from accumulated other comprehensive income (loss) to income for the three and six nine months ended June September 30, 2026 and 2025 were as follows:

1 unchanged paragraph

Details About Accumulated Other Comprehensive Income Components Three Months Ended June September 30, Six Nine Months Ended June September 30, Affected Line Item in the Statements of Operations (in millions)

1 unchanged paragraph

30 — 30 — Net income

Commodity derivatives $ 16 19 $ — $ 16 35 $ — Cost of sales

Foreign currency derivatives 19 20 — 19 39 — Cost of sales

35 39 — 35 74 — Income before income taxes and equity income

( 5 6 ) — ( 5 11 ) — Income tax expense

33 — 63 — Net income

— — — — Net (loss) income attributable to noncontrolling interest

$ 30 33 $ — $ 30 63 $ — Net income attributable to Versigent

1 unchanged paragraph

Actuarial loss $ — $ ( 1 ) $ — $ ( 1 ) Other expense, net (1)

Settlement loss ( 2 1 ) — ( 2 3 ) — Other expense, net (1)

( 2 1 ) ( 1 ) 2 ( 3 ) ( 1 ) Income before income taxes and equity income ( 2 1 ) ( 1 ) 2 ( 3 ) ( 1 ) Net income

— — — — Net (loss) income attributable to noncontrolling interest

$ ( 2 1 ) $ ( 1 ) $ ( 2 3 ) $ ( 1 ) Net income attributable to Versigent

Total reclassifications for the period $ 28 32 $ ( 1 ) $ 28 60 $ ( 1 )

1 unchanged paragraph

Note 16: DERIVATIVES AND HEDGING ACTIVITIES 33 changes

1 unchanged paragraph

As of June September 30, 2026, the Company had the following outstanding notional amounts related to commodity and foreign currency forward and option contracts designated as cash flow hedges that were entered into to hedge forecasted exposures:

3 unchanged paragraphs

Copper 57,556 pounds $ 354

Copper 54,026 pounds $ 355

1 unchanged paragraph

Mexican Peso 17,902 MXN $ 1,022

Chinese Yuan Renminbi 1,238 RMB $ 182

Mexican Peso 18,912 MXN $ 1,051

Chinese Renminbi 1,247 RMB $ 186

As of June September 30, 2026, Versigent has entered into derivative instruments to hedge cash flows extending out to June September 2028.

Gains and losses on derivatives qualifying as cash flow hedges are recorded in accumulated OCI, to the extent that hedges are effective, until the underlying transactions are recognized in earnings. Unrealized amounts in accumulated OCI will fluctuate based on changes in the fair value of hedge derivative contracts at each reporting period. Net gains on cash flow hedges included in accumulated OCI as of June September 30, 2026 were $ 125 89 million (approximately $ 106 76 million, net of tax). Of this total, approximately $ 102 83 million of gains are expected to be included in cost of sales within the next 12 months and approximately $ 23 6 million of gains are expected to be included in cost of sales in subsequent periods. Cash flow hedges are discontinued when Versigent determines it is no longer probable that the originally forecasted transactions will occur. Cash flows from derivatives used to manage commodity and foreign exchange risks designated as cash flow hedges are classified as operating activities within the consolidated statements of cash flows.

3 unchanged paragraphs

The fair value of derivative financial instruments recorded in the consolidated balance sheet as of June September 30, 2026 is as follows:

1 unchanged paragraph

Balance Sheet Location June September 30,

2026 Balance Sheet Location June September 30,

1 unchanged paragraph

Commodity derivatives Other current assets $ 40 46 Accrued liabilities $ — $ 40 46

Foreign currency derivatives* Other current assets 60 29 Other current assets 3 $ 57 4 25

Commodity derivatives Other long-term assets 10 9 Other long-term liabilities — 10 9

Foreign currency derivatives* Other long-term assets 11 1 Other long-term assets — 1 10

Foreign currency derivatives* Other long-term liabilities — Other long-term liabilities 3 ( 3 )

Total derivatives designated as hedges $ 121 85 $ 4 7

1 unchanged paragraph

Foreign currency derivatives* Other current assets $ — 1 Other current assets $ 1 $ ( 1 —

Foreign currency derivatives* Accrued liabilities — Accrued liabilities 2 ( 2 )

Total derivatives not designated as hedges $ — $ 1 $ 3

1 unchanged paragraph

The fair value of Versigent's derivative financial instruments were in a net asset position as of June September 30, 2026.

1 unchanged paragraph

The pre-tax effects of derivative financial instruments in the consolidated statements of operations and consolidated statements of comprehensive income for the three and six nine months ended June September 30, 2026 are as follows:

Three Months Ended June September 30, 2026 Gain (Loss) Recognized in OCI Gain Reclassified from OCI into Income (in millions)

1 unchanged paragraph

Commodity derivatives $ 23 $ 16

Commodity derivatives $ 24 $ 19

Foreign currency derivatives 34 19 ( 21 ) 20

3 unchanged paragraphs

Six Nine Months Ended June September 30, 2026 Gain (Loss) Recognized in OCI Gain Reclassified from OCI into Income (in millions)

1 unchanged paragraph

Commodity derivatives $ 66 $ 16

Commodity derivatives $ 90 $ 35

Foreign currency derivatives 94 19 73 39

2 unchanged paragraphs

Foreign currency derivatives $ 2 ( 3 )

The gain or loss recognized in income for designated and non-designated derivative instruments was recorded to cost of sales and other expense, net in the consolidated statements of operations for the three and six nine months ended June September 30, 2026.

1 unchanged paragraph

Note 17: FAIR VALUE OF FINANCIAL INSTRUMENTS 17 changes

3 unchanged paragraphs

As of June September 30, 2026, Versigent was in a net derivative asset position of $ 116 76 million, and no significant adjustments were recorded based on the evaluation of our own nonperformance risk and because Versigent's exposures were to counterparties with investment grade credit ratings.

As of June September 30, 2026, Versigent had the following assets measured at fair value on a recurring basis:

3 unchanged paragraphs

Commodity derivatives $ 50 $ — $ 50 $ —

Total $ 116 $ — $ 116 $ —

As of June September 30, 2026:

Commodity derivatives $ 55 $ — $ 55 $ —

Foreign currency derivatives 66 26 — 66 26 —

Total $ 81 $ — $ 81 $ —

As of September 30, 2026, Versigent had the following liabilities measured at fair value on a recurring basis:

Total Quoted Prices in Active Markets

Level 1 Significant Other Observable Inputs

Level 2 Significant Unobservable Inputs

As of September 30, 2026:

Foreign currency derivatives $ 5 $ — $ 5 $ —

Total $ 5 $ — $ 5 $ —

Non-derivative financial instruments —Versigent's non-derivative financial instruments include cash and cash equivalents, accounts and notes receivable, accounts payable, as well as debt, which may consist of accounts receivable factoring arrangements, finance leases and other debt issued by Versigent's non-U.S. subsidiaries, the Credit Facilities and all series of outstanding senior notes. The fair value of debt is developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. As of June September 30, 2026 total debt was recorded at $ 2,224 2,124 million and had an estimated fair value of $ 2,245 2,075 million. For all other financial instruments recorded at June September 30, 2026, fair value approximates book value.

1 unchanged paragraph

In addition to items that are measured at fair value on a recurring basis, Versigent also has items in its balance sheet that are measured at fair value on a nonrecurring basis. As these items are not measured at fair value on a recurring basis, they are not included in the tables above. Financial and nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include long-lived assets, intangible assets, equity investments without readily determinable fair values and liabilities for exit or disposal activities measured at fair value upon initial recognition. Versigent recorded non-cash long-lived asset impairment charges which were de minimis and of $ 7 million and $ 14 million during the three and six nine months ended June September 30, 2026, respectively, within cost of sales, primarily related to the declines in the fair value of certain fixed long-lived assets and a planned site exit. The Company recorded long-lived asset impairments of impairment charges which were de minimis and $ 3 million during both the three and six nine months ended June September 30, 2025, respectively. Fair value of long-lived and other assets is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved and a review of appraisals or other market indicators and management estimates. As such, Versigent has determined that the fair value measurements of long-lived and other assets principally fall in Level 3 of the fair value hierarchy.

Note 18: OTHER EXPENSE, NET 8 changes

1 unchanged paragraph

Three Months Ended June 30, Six Months Ended June 30,

Interest income $ — $ 1 $ 3 $ 2

Other expense, net $ ( 6 ) $ — $ ( 7 ) $ ( 1 )

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Interest income $ 7 $ 3 $ 10 $ 5

Components of net periodic benefit cost other than service cost (Note 11) ( 6 ) ( 2 ) ( 15 21 ) ( 4 6 )

Other, net ( 3 ) ( 1 ) 2 —

Other expense, net $ ( 2 ) $ — $ ( 9 ) $ ( 1 )

Note 19: SHARE-BASED COMPENSATION 12 changes

4 unchanged paragraphs

All RSUs granted under the PLC LTIP, including adjusted and converted equity awards under the Former Parent Plan, are eligible to receive dividend equivalents for any dividend paid from the grant date through the vesting date. Dividend equivalents are generally paid out in ordinary shares upon vesting of the underlying RSUs.

25 unchanged paragraphs

Granted 1,112 $ 36.41

Vested ( 135 ) $ 60.12

Forfeited ( 33 ) $ 64.98

Granted 1,134 $ 36.60

Vested ( 180 ) $ 52.52

Forfeited ( 42 ) $ 58.84

1 unchanged paragraph

Nonvested, June 30, 2026 (2) 2,332 $ 33.36

Nonvested, September 30, 2026 (2) 2,300 $ 33.52

1 unchanged paragraph

(2) Nonvested RSUs and the corresponding weighted average grant date fair value as of June September 30, 2026 are presented on a Versigent basis using the conversion factor described above in connection with the Spin-Off.

Share-based compensation expense related to these RSUs, which for periods prior to the Spin-Off includes the cost of Versigent employees who participated in the Former Parent plan as well as an allocated portion of the cost of Former Parent senior management awards, was $ 11 9 million ($ 11 9 million, net of tax) and $ 8 million ($ 7 million, net of tax) based on the Company's best estimate of ultimate performance against the respective targets during the three months ended June September 30, 2026 and 2025, respectively. Share-based compensation expense recorded within the consolidated statement of operations included $ 19 28 million ($ 18 27 million, net of tax) and $ 16 24 million ($ 14 21 million, net of tax) during the six nine months ended June September 30, 2026 and 2025, respectively.

Versigent will continue to recognize compensation expense, based on the grant date fair value of the awards applied to the Company's best estimate of ultimate performance against the respective targets, over the requisite vesting periods of the awards. Based on the grant date fair value of the awards and the Company's best estimate of ultimate performance against the respective targets as of June September 30, 2026, unrecognized compensation expense on a pretax basis of approximately $ 72 63 million is anticipated to be recognized over a weighted average period of approximately 2 years.

Note 20: SEGMENT REPORTING AND REVENUE 60 changes

2 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Net sales $ 2,444 $ 2,206 $ 4,656 $ 4,230

Cost of sales 2,123 1,943 4,091 3,718

Selling, general and administrative 100 104 197 209

Included below are segment net sales, significant expenses and operating data for the three and six nine months ended June September 30, 2026 and 2025:

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Net sales $ 2,450 $ 2,286 $ 7,106 $ 6,516

Cost of sales 2,120 1,990 6,211 5,708

Selling, general and administrative 112 104 309 313

1 unchanged paragraph

Net income $ 116 $ 112 $ 197 $ 208

Net income $ 112 $ 113 $ 309 $ 321

1 unchanged paragraph

Three Months Ended June 30, Six Months Ended June 30,

Income tax expense $ ( 46 ) $ ( 21 ) $ ( 37 ) $ ( 50 )

Other expense, net $ ( 6 ) $ — $ ( 7 ) $ ( 1 )

Interest expense $ ( 36 ) $ ( 1 ) $ ( 41 ) $ ( 3 )

Separation costs $ ( 22 ) $ ( 2 ) $ ( 48 ) $ ( 7 )

Restructuring $ — $ ( 25 ) $ ( 46 ) $ ( 41 )

Depreciation and amortization (1) $ ( 51 ) $ ( 59 ) $ ( 112 ) $ ( 111 )

Capital expenditures $ ( 51 ) $ ( 42 ) $ ( 117 ) $ ( 79 )

Included below is additional segment information for the three and six nine months ended June September 30, 2026 and 2025:

Three Months Ended September 30, Nine Months Ended September 30, (in USD millions)

Income tax expense ( 35 ) ( 54 ) ( 72 ) ( 104 )

Equity income, net $ 5 $ — 3 $ 9 $ 8 11

Amortization $ — $ — 1 ( $ ( 1 ) $ ( 1 )

Other expense, net ( 2 ) — ( 9 ) ( 1 )

Interest expense ( 36 ) — ( 77 ) ( 3 )

Separation costs ( 11 ) ( 7 ) ( 59 ) ( 14 )

Restructuring ( 22 ) ( 21 ) ( 68 ) ( 62 )

Depreciation and amortization (1) ( 55 ) ( 55 ) ( 167 ) ( 166 )

Capital expenditures ( 55 ) ( 44 ) ( 172 ) ( 123 )

(1) Segment depreciation and amortization is included within segment cost of sales, selling, general and administrative expense and amortization expense disclosed.

Included below is balance sheet data as of June September 30, 2026 and December 31, 2025:

June September 30, 2026 December 31, 2025

Investments in affiliates $ 149 $ 146 143

Segment assets $ 5,359 $ 5,527 4,485

5 unchanged paragraphs

Three Months Ended June 30, Six Months Ended June 30,

Low Voltage Electrical Architecture 2,222 1,945 4,227 3,745

High Voltage Electrical Architecture $ 222 $ 261 $ 429 $ 485

Total net sales $ 2,444 $ 2,206 $ 4,656 $ 4,230

Revenue by product line for the three and six nine months ended June September 30, 2026 and 2025 is as follows:

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

Low-Voltage Electrical Architecture $ 2,208 $ 2,041 $ 6,435 $ 5,786

High-Voltage Electrical Architecture 242 245 671 730

Total net sales $ 2,450 $ 2,286 $ 7,106 $ 6,516

1 unchanged paragraph

Three Months Ended June 30, Six Months Ended June 30,

North America $ 1,022 $ 921 $ 1,919 $ 1,743

Europe, Middle East & Africa 524 555 1,033 1,068

South America 73 63 140 116

Total net sales $ 2,444 $ 2,206 $ 4,656 $ 4,230

Net sales reflects the manufacturing location and is for the three and six nine months ended June September 30, 2026 and 2025.

Three Months Ended September 30, Nine Months Ended September 30, (in millions)

North America $ 1,027 $ 965 $ 2,946 $ 2,708

Europe, Middle East & Africa 471 501 1,504 1,569

South America 84 86 224 202

Total net sales $ 2,450 $ 2,286 $ 7,106 $ 6,516

Consistent with the recognition of production parts revenue at a point in time title transfers to the customer, the Company has no contract assets or contract liabilities balances as of June September 30, 2026 and December 31, 2025.

4 unchanged paragraphs

From time to time, the Company makes payments to customers in conjunction with ongoing business. These payments to customers are generally one-time, upfront payments made in connection with the award of new business to us and are recognized as a reduction to revenue at the time of the commitment to make these payments. The amount of these payments was not significant for the six nine months ended June September 30, 2026 and 2025.

However, certain of these payments to customers, or upfront fees, are capitalized as they are directly attributable to a contract, are incremental and management expects the fees to be recoverable. As of June September 30, 2026 and December 31, 2025, the Company has recorded $ 30 31 million (of which $ 5 million was classified within other current assets and $ 25 26 million was classified within other long-term assets) and $ 33 million (of which $ 7 million was classified within other current assets and $ 26 million was classified within other long-term assets), respectively, related to these capitalized upfront fees.

Capitalized upfront fees are amortized to revenue based on the transfer of goods and services to the customer for which the upfront fees relate, which typically range from three to five years . There have been no impairment losses in relation to the costs capitalized. The amount of amortization to net sales was $ 2 million and $ 1 million for both the three months ended June September 30, 2026 and 2025, respectively, and $ 3 5 million and $ 2 3 million for the six nine months ended June September 30, 2026 and 2025, respectively.

1 unchanged paragraph

This Quarterly Report on Form 10-Q, including the exhibits being filed as part of this report, as well as other statements made by Versigent ("Versigent," the "Company," "we," "us" and "our"), contain forward-looking statements that reflect, when made, the Company's current views with respect to current events, certain investments and acquisitions, business plans and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to the Company's operations and business environment, which may cause the actual results of the Company to be materially different from any future results, expressed or implied, by such forward-looking statements. All statements that address future operating, financial or business performance or the Company's strategies or expectations are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "projects," "potential," "outlook" or "continue," and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: disruptions in the supply of raw materials and other supplies integral to our products; future significant public health crises and other global health crises and the measures taken in response thereto; a prolonged recession and/or a downturn in global automotive sales; the volatile global economic environment and geopolitical conditions, including conditions affecting the credit market and global inflationary pressures; our reliance on relationships with collaborative partners and other third parties for product development and such parties' failure to perform; employee strikes and labor-related disruptions involving us or one or more of our customers affecting our operations; fluctuations in interest rates and foreign currency exchange rates; our failure to comply with the numerous laws and regulations to which we are subject; adverse developments affecting one or more of our suppliers; any adverse impact of legal proceedings and disputes in which we are involved; challenges to our historical and future tax positions by taxing authorities; an increase in our tax burden due to ongoing or future tax audits; our failure to attract and retain key salaried employees and management personnel; our failure to manage the transition to a standalone public company; and our failure to achieve some or all of the benefits expected from the our recently completed spin-off. Additional factors are discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's filings with the Securities and Exchange Commission, including those set forth in the Company's Information Statement furnished with the Company's Registration Statement on Form 10-12B/A filed on March 6, 2026. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect the Company. It should be remembered that the price of the ordinary shares and any income from them can go down as well as up. Versigent disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.

MD&A 1 change

The following management's discussion and analysis of financial condition and results of operations ("MD&A") is intended to help you understand the business operations and financial condition of Versigent PLC ("Versigent") for the three and six nine months ended June September 30, 2026. This discussion should be read in conjunction with Item 1. Financial Statements. Our MD&A is presented in the following sections:

15 unchanged paragraphs

Business 198 changes

2 unchanged paragraphs

We also develop, manufacture and sell our solutions to a number of adjacent end markets. including These markets include our commercial vehicles business, as well as agriculture, construction, and grid and infrastructure, and we have begun penetrating exploring other industrial end markets, including off-grid power storage and robotics. With a proven portfolio of solutions, we expect to leverage our long-standing customer relationships, technical expertise within power, data and signal distribution, and capabilities built serving the global automotive industry to further penetrate these adjacent markets.

5 unchanged paragraphs

In addition, we continue to manage inventory levels to support customers' vehicle production schedules. As of June September 30, 2026 and December 31, 2025, we have not experienced significant raw material shortages; however, inventory levels have remained elevated due to recent OEM production volatility and cancellations. We are actively managing inventory to balance supply continuity and working capital efficiency.

8 unchanged paragraphs

Pricing . Cost reduction initiatives adopted by our customers continue to drive pricing pressure, including contractual step-downs in component pricing over program life cycles. Our profitability depends on our ability to offset these reductions through operational efficiencies and cost savings. Inflationary pressures and evolving trade policies have increased costs and we continue to pursue price commercial recoveries and contractual adjustments remedies to mitigate these impacts.

We maintain a flexible cost structure, with a significant portion of our hourly workforce located in best cost countries and approximately 34% 37% contingent labor as of June September 30, 2026. We continue to optimize our manufacturing footprint and cost structure through restructuring and operational initiatives to align capacity with demand and support investment in advanced technologies.

1 unchanged paragraph

Operational performance. We pursue operational execution and continuous improvement initiatives intended to help offset the impact of labor and other cost inflation, project-related expenses, and launch costs as we continue to grow the business. These initiatives include, but are not limited to, purchasing cost savings, material productivity improvements, value engineering, content optimization, and manufacturing productivity and footprint optimization actions. The timing, magnitude, and effectiveness of these initiatives may impact our costs, margins, and operating results.

1 unchanged paragraph

Three Months Ended June 30, Six Months Ended June 30,

Three and Six Nine Months Ended June September 30, 2026 versus Three and Six Nine Months Ended June September 30, 2025

The Company's results of operations for the three and six nine months ended June September 30, 2026 and 2025 were as follows:

Three Months Ended September 30, Nine Months Ended September 30,

1 unchanged paragraph

(dollars in millions)

Net sales $ 2,444 $ 2,206 $ 238 $ 4,656 $ 4,230 $ 426

Cost of sales 2,123 1,943 (180) 4,091 3,718 (373)

Gross margin 321 13.1% 263 11.9% 58 565 12.1% 512 12.1% 53

Selling, general and administrative 100 104 4 197 209 12

Restructuring — 25 25 46 41 (5)

Separation costs 22 2 (20) 48 7 (41)

Operating income 199 131 68 273 254 19

Interest expense (36) (1) (35) (41) (3) (38)

Other expense, net (6) — (6) (7) (1) (6)

Income tax expense (46) (21) (25) (37) (50) 13

Income before equity income 111 109 2 188 200 (12)

Equity income, net of tax 5 3 2 9 8 1

Net income 116 112 4 197 208 (11)

Net (loss) income attributable to noncontrolling interest (2) 5 (7) 1 6 (5)

Net sales $ 2,450 $ 2,286 $ 164 $ 7,106 $ 6,516 $ 590

Cost of sales 2,120 1,990 (130) 6,211 5,708 (503)

Gross margin 330 13.5% 296 12.9% 34 895 12.6% 808 12.4% 87

Selling, general and administrative 112 104 (8) 309 313 4

Amortization — 1 1 — — 1 1 —

Restructuring 22 21 (1) 68 62 (6)

Separation costs 11 7 (4) 59 14 (45)

2 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

2 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

4 unchanged paragraphs

1 unchanged paragraph

2 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

3 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

4 unchanged paragraphs

1 unchanged paragraph

4 unchanged paragraphs

3 unchanged paragraphs

1 unchanged paragraph

3 unchanged paragraphs

2 unchanged paragraphs

and 167 more changes in the filing

Market risk 1 change

and 1 more change in the filing

Controls and procedures 2 changes

3 unchanged paragraphs

1 unchanged paragraph

and 2 more changes in the filing

Other information 16 changes

and 16 more changes in the filing

Exhibits 8 changes

6 unchanged paragraphs

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

1 unchanged paragraph

18 unchanged paragraphs

and 8 more changes in the filing